Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Donehower

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Molecular Carcinogenesis|September 1, 1995
Effects of genetic background on tumorigenesis in p53-deficient miceL A Donehower, M Harvey, H Vogel, et al.
Progress in Clinical and Biological Research|January 1, 1996
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer modelL A Donehower, L A Godley, C M Aldaz, et al.
Oncogene|May 4, 1995
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 lossK Blyth, A Terry, M O'Hara, et al.
Cancer Research|May 1, 1995
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patientsS Rong, L A Donehower, M F Hansen, et al.
Genes & Development|April 1, 1995
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instabilityL A Donehower, L A Godley, C M Aldaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2000
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiersR B Halberg, D S Katzung, P D Hoff, et al.
Oncogene|September 1, 1993
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient miceM Harvey, A T Sands, R S Weiss, et al.
Mutation Research|October 11, 2003
Transgenic tumor models for carcinogen identification: the heterozygous Trp53-deficient and RasH2 mouse linesR D Storer, J E French, L A Donehower, et al.
Genes & Development|June 20, 2000
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpointQ Liu, S Guntuku, X S Cui, et al.
Cancer Research|April 15, 1995
Defective G2 checkpoint function in cells from individuals with familial cancer syndromesR S Paules, E N Levedakou, S J Wilson, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Molecular Carcinogenesis|September 1, 1995
Effects of genetic background on tumorigenesis in p53-deficient miceL A Donehower, M Harvey, H Vogel, et al.
Progress in Clinical and Biological Research|January 1, 1996
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer modelL A Donehower, L A Godley, C M Aldaz, et al.
Oncogene|May 4, 1995
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 lossK Blyth, A Terry, M O'Hara, et al.
Cancer Research|May 1, 1995
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patientsS Rong, L A Donehower, M F Hansen, et al.
Genes & Development|April 1, 1995
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instabilityL A Donehower, L A Godley, C M Aldaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2000
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiersR B Halberg, D S Katzung, P D Hoff, et al.
Oncogene|September 1, 1993
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient miceM Harvey, A T Sands, R S Weiss, et al.
Mutation Research|October 11, 2003
Transgenic tumor models for carcinogen identification: the heterozygous Trp53-deficient and RasH2 mouse linesR D Storer, J E French, L A Donehower, et al.
Genes & Development|June 20, 2000
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpointQ Liu, S Guntuku, X S Cui, et al.
Cancer Research|April 15, 1995
Defective G2 checkpoint function in cells from individuals with familial cancer syndromesR S Paules, E N Levedakou, S J Wilson, et al.
Pageof 9